Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 74, Issue 2, 2010, Pages 209-218

  Sajeesh, S ^a,b   Bouchemal, K ^b   Sharma, C P ^a   Vauthier, C ^b  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^b UNIV PARIS SUD   (France)

Author keywords

Hydrogels; Intestinal absorption; Microparticles; Mucoadhesion; Thiolation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CARBOXYLIC ACID; CYANAMIDE; CYSTEINE; DEXTRAN; DRUG CARRIER; POLYMETHACRYLIC ACID MACROGOL CHITOSAN; THIOL GROUP; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLUORESCENCE ANALYSIS; GELATION; HYDROGEL; INTESTINE MUCOSA PERMEABILITY; LIGHT SCATTERING; MALE; MUCOADHESION; NONHUMAN; ORAL DRUG DELIVERY SYSTEM; PARTICLE SIZE; QUANTITATIVE ANALYSIS; RAT;

EID: 75449113014     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.09.001     Document Type: Article

References (31)

1. Prego C., Garci{dotless}a M., Torres D., and Alonso M.J. Transmucosal macromolecular drug delivery. J. Control. Release 101 (2005) 151-162
2. Miyoshi J., and Takai Y. Molecular perspective on tight-junction assembly and epithelial polarity. Adv. Drug Del. Rev. 57 (2005) 815-855
3. Salama N.N., Eddington D.N.D., and Fasano A. Tight junction modulation and its relationship to drug delivery. Adv. Drug Del. Rev. 58 (2006) 15-28
4. Maher S., Brayden D.J., Feighery L., and McClean S. Cracking the junction: update on the progress of gastrointestinal absorption enhancement in the delivery of poorly absorbed drugs. Crit. Rev. Ther. Drug Car. Syst. 25 (2008) 117-168
5. Siccardi D., Turner J.R., and Mrsny R.J. Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease. Adv. Drug Del. Rev. 57 (2005) 219-235
6. Thanou M., Verhoef J.C., and Junginger H.E. Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Del. Rev. 50 (2001) S91-S101
7. Foss A.C., and Peppas N.A. Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures. Eur. J. Pharm. Biopharm. 57 (2004) 447-455
8. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 89 (2000) 429-442
9. Rekha M.R., and Sharma C.P. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J. Control. Release 135 (2009) 144-151
10. Junginger H.E., and Verhoef J.C. Macromolecules as safe penetration enhancers for hydrophilic drugs - a fiction?. Pharm. Sci. Technol. Today 1 (1998) 370-376
11. Collares-Buzato C.B., Jepson M.A., Simmons N.L., and Hirst B.H. Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia. Eur. J. Cell Biol. 76 (1998) 85-92
12. Staddon J.M., Herrenknecht K., Smales C., and Rubin L.L. Evidence that tyrosine phosphorylation may increase tight junction permeability. J. Cell Sci. 108 (1995) 609-619
13. Smith J., Wood E., and Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm. Res. 21 (2004) 43-49
14. Ma Z., and Lim L.Y. Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. Pharm. Res. 20 (2003) 1812-1819
15. Albrecht K., and Bernkop-Schnürch A. Thiomers: forms, functions and applications to nanomedicine. Nanomedicine 2 (2007) 41-50
16. Leitner V.M., Walker G.F., and Bernkop-Schnürch A. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur. J. Pharm. Biopharm. 56 (2003) 207-214
17. Bernkop-Schnürch A., Kast C.E., and Guggi D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J. Control. Release 93 (2003) 95-103
18. Bravo-Osuna I., Ponchel G., and Vauthier C. Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles. Eur. J. Pharm. Sci. 30 (2007) 143-154
19. Bravo-Osuna I., Schmitz T., Bernkop-Schnürch A., Vauthier C., and Ponchel G. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Int. J. Pharm. 316 (2006) 170-175
20. Bravo-Osuna I., Vauthier C., Chacun H., and Ponchel G. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Eur. J. Pharm. Biopharm. 69 (2008) 436-444
21. Bravo-Osuna I., Vauthier C., Farabollini A., Palmieri G.F., and Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 28 (2007) 2233-2243
22. Sajeesh S., and Sharma C.P. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery. J. Biomed. Mater. Res. Appl. Biomater. 76B (2006) 298-305
23. Sajeesh S., and Sharma C.P. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm. 325 (2006) 147-154
24. Nobs L., Buchegger F., Gurny R., and Allemann E. Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. Int. J. Pharm. 250 (2003) 327-337
25. Hombach J., Hoyer H., and Bernkop-Schnürch A. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system. Eur. J. Pharm. Sci. 33 (2008) 1-8
26. Sajeesh S., and Sharma C.P. Novel polyelectrolyte complex microparticles based on poly(methacrylic acid)-2 (amino propyl) poly(ethylene glycol) for oral protein delivery. J. Biomater. Sci. Poly. Edit. 18 (2007) 1125-1139
27. Dorkoosh F.A., Setyaningsh D., Borchard G., Rafiee-Tehrani M., Verhoef J.C., and Junginger H.E. Effect of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cells monolayers. Int. J. Pharm. 241 (2002) 35-41
28. Peppas N.A., and Huang Y. Nanoscale technology of mucoadhesive interactions. Adv. Drug Del. Rev. 56 (2004) 1675-1687
29. Varum F.J., McConnell E.L., Sousa J.J., Veiga F., and Basit A.W. Mucoadhesion and the gastrointestinal tract. Crit. Rev. Ther. Drug Car. Syst. 25 (2008) 207-258
30. Hillgren K.M., Kato A., and Borchardt R.T. In vitro systems for studying intestinal drug absorption. Med. Res. Rev. 15 (1995) 83-109
31. Cone R.A. Barrier properties of mucus. Adv. Drug Del. Rev. 61 (2009) 75-85